Publikationen

Home >> Forschung >> Publikationen


Impact Factor


Januar 2026
ACS Nano
Basak S, Vu KC, Mougios N, Oleksiievets N, Pollack YG, Brandenburg S, Opazo F, Lehnart SE, Enderlein J, Tsukanov R
Dezember 2025
Cell Death & Disease
Wendland K, Irsfeld M, Schreiber K, Ternka K, Stadelmann C, Nessler S, Gärtner J, Kettwig M
Dezember 2025
Neurology: Neuroimmunology and Neuroinflammation
Landt C, Held F, Kolotourou K, Guranda M, Vakrakou AG, Franz J, Thomas C, Schmiedeknecht MUH, Bergann K, Wrzos C, Endmayr V, Tsaktanis T, Zechel S, Ancău M, Misgeld T, Hakroush S, Hametner S, Rothhammer V, Höftberger R, Hemmer B, Stadelmann C, Nessler S
Dezember 2025
Arxiv
Dvoretskii S, Archit A, Pape C, Moore J, Nolden M
Dezember 2025
BioRxiv
Basak S, Inamdar K, Pollack YG, Albert L, Jans DC, Jakobs S, Enderlein J, Tsukanov R, Opazo F
Dezember 2025
IEEE Transactions on Medical Imaging
Archit A, Freckmann L, Pape C
Dezember 2025
Science Advances
Maestro-Lopez M, Cheng TC, Muntaner J, Menendez M, Alonso M, Schweitzer A, Ishizaka M, Tomko Jr. RJ, Cuellar J, Valpuesta JM, Sakata E
Dezember 2025
Europace
Svennberg E, Merino JL, Andrade J, Anselmino M, Arbelo E, Boersma E, Boriani G, Breithardt G, Chung M, Chyou J, Cohen A, Nielsen JC, Dichtl W, Diederichsen SZ, Dobrev D, Doehner W, Dworatzek E, Fabritz L, Filgueiras-Rama D, Gimpelewitz C, Hack G, Hatem S, Healey J, Heidbuchel H, Hijazi Z, Holst AG, Hove-Madsen L, Jalife J, van Leerdam R, Linz D, Lip GYH, Lubitz S, de Melis M, Meyer R, Orczykowski M, Parwani AS, Porta-Sanchez A, de Potter T, Ravens U, Rienstra M, Rillig A, Rivard L, Scherr D, Schnabel RB, Schotten U, Simovic S, Sinner M, Sohns C, Sommer P, Steinbeck G, Steven D, Sultan A, Thomalla G, Toennis T, Tzeis S, Voigt N, Wadhwa M, Wakili R, Witt H, Goette A, Kirchhof P
Dezember 2025
Arxiv
Müller L, Sartori F, Dehning J, Eggl MF, Priesemann V

Authors

Müller L, Sartori F, Dehning J, Eggl MF, Priesemann V

Journal

Arxiv

Citation

arXiv:2512.11454.

Abstract

Mitigation measures are essential for controlling the spread of infectious diseases during pandemics and epidemics, but they impose considerable societal, individual, and economic costs. We developed a general optimization framework to balance costs related to infection and to mitigation. Optimizing the trade-off between mitigation and infection cost, we identified three novel, surprising effects: First, assuming a constant reproduction number R0, the optimal response to an infectious disease requires either strict mitigation or none at all, depending on disease severity, but never does one find an intermediate mitigation level to be optimal. Second, under seasonal variations, optimal mitigation is stricter during winter. Interestingly, a single wave of infections still arises in spring with 3 months delay to the seasonal peak of infectivity, replacing the autumn/winter waves known for classical influenza. Third, during steady vaccination campaigns, even optimal mitigation can result in transient infection waves. Finally, we quantify the cost of delayed mitigation onset and show that even short delays can substantially increase total costs — if the disease is severe. Overall, our framework is easily applicable to general and complex settings and thereby presents a versatile tool to explore optimal mitigation strategies for endemic and pandemic infectious disease.

DOI

arXiv.2512.11454

X
EN DE
X
X